The BiofloTM PICC with Endexo and PASV technologies provides safe and reliable mid to long-term intravenous access.
Reduce Thrombus Accumulation by 87%1
The surface modifying Endexo polymer is “blended” with the polyurethane catheter material making it permanently more resistant to thrombus accumulation, a precursor of deep vein thrombosis and partial withdrawal occlusion.
Reduce Catheter Occlusions by 78%2
The bi-directional Pressure Activated Safety Valve (PASV) is in the proximal port and is proven to minimise blood reflux caused by changes in thoracic pressure. The PASV negates the need for positive pressure needle free connectors and clamps which can irritate the skin.
CT Rated and Clear Identification
All BioFlo catheters are CT-rated and max flow rates are clearly labelled on the purple hubs for the BioFlo PASV catheters and on the clamps of the BioFlo Non-PASV catheters.
Whether you are setting up a new Vascular Access Service or are part of an experienced Radiology, Theatre or IV team we understand the challenges that arise. With ECG Tip Location systems, our market leading Customised Procedure Pack Service and online educational training we can tailor our support to your individual needs.
Please fill in an enquiry form to schedule a call back from our Product Manager.
1. In vitro blood loop model test results demonstrated on average 87% less thrombus accumulation.
2. Burns, D. Retrospective Analysis The Vanderbilt PICC service: Program, Program, Procedural and Patient Outcomes Success, Vanderbilt University. JAVA Vol.10 No. 42005.
BioFloTM is a trademark of AngioDynamics® and is distributed by Kimal PLC in the UK excluding Northern Ireland.